RACE-RELATED GERMLINE GENETIC VARIATION AND RESPONSE TO SECONDARY HORMONAL THERAPY IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
$1,587,896FY2019Defense Health AgencyDOD
Duke University, Durham NC
Investigators
View source on USAspending →RACE-RELATED GERMLINE GENETIC VARIATION AND RESPONSE TO SECONDARY HORMONAL THERAPY IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER · GrantIndex